首页> 外国专利> METHOD FOR PREDICTING EFFECTIVENESS OF OLANZAPINE ATYPICAL ANTIPSYCHOTIC DRUG THERAPY IN SCHIZOPHRENIA PATIENTS

METHOD FOR PREDICTING EFFECTIVENESS OF OLANZAPINE ATYPICAL ANTIPSYCHOTIC DRUG THERAPY IN SCHIZOPHRENIA PATIENTS

机译:预测精神分裂症患者奥氮平非典型抗精神病药物治疗的疗效的方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, namely to psychiatry, and can be used to predict the effectiveness of treatment of schizophrenia patients with the olanzapine atypical antipsychotic drug. For this purpose, immune status of patients with schizophrenia is analyzed before the start of therapy, the level of cortisol in the blood serum is determined and with the simultaneous content of T-helper/inducer (CD4+) more than 41 %, natural killers (CD16+) more than 11 %, serum levels of cortisol of more than 727 nmol/l the high effectiveness of atypical antipsychotic drug therapy is predicted.;EFFECT: invention provides an expansion of the arsenal of methods for predicting the effectiveness of therapy for patients with schizophrenia before prescribing active psychopharmacological treatment with antipsychotics.;1 cl, 1 tbl, 2 ex
机译:药物领域本发明涉及药物,即精神病学,可用于预测奥氮平非典型抗精神病药对精神分裂症患者的治疗效果。为此,在开始治疗之前分析精神分裂症患者的免疫状况,确定血清中皮质醇的水平,并同时测定T-辅助剂/诱导剂(CD4 + )预计超过41%的自然杀手(CD16 + )超过11%的皮质醇血清水平超过727 nmol / l,这是非典型抗精神病药物疗法的高效疗效。在开具抗精神病药的积极心理药理学治疗方法之前,预测精神分裂症患者的治疗方法的方法库的扩展。1cl,1 tbl,2 ex

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号